EFTRENONACOG ALFA for Factor viii deficiency: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where EFTRENONACOG ALFA was used for Factor viii deficiency.
Most Reported Side Effects for EFTRENONACOG ALFA
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Haemorrhage | 802 | 37.5% | 0 | 82 |
| Haemarthrosis | 196 | 9.2% | 0 | 31 |
| Fall | 151 | 7.1% | 0 | 36 |
| Contusion | 108 | 5.1% | 0 | 15 |
| Arthralgia | 104 | 4.9% | 0 | 13 |
| Traumatic haemorrhage | 93 | 4.4% | 0 | 14 |
| Limb injury | 83 | 3.9% | 0 | 8 |
| Head injury | 76 | 3.6% | 0 | 24 |
| Epistaxis | 73 | 3.4% | 0 | 11 |
| Spontaneous haemorrhage | 71 | 3.3% | 0 | 6 |
| Joint injury | 63 | 3.0% | 0 | 5 |
| Joint swelling | 62 | 2.9% | 0 | 11 |
| Pain | 61 | 2.9% | 0 | 13 |
| Muscle haemorrhage | 46 | 2.2% | 0 | 3 |
| Injury | 45 | 2.1% | 0 | 8 |
Other Indications for EFTRENONACOG ALFA
Factor ix deficiency (1,133)
Haemophilia (148)
Haemorrhage (109)
Product used for unknown indication (93)
Prophylaxis (77)
Haemorrhage prophylaxis (34)
Immune tolerance induction (16)
Haemarthrosis (6)
Other Drugs Used for Factor viii deficiency
EMICIZUMAB-KXWH (6,532)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT (4,268)
EFMOROCTOCOG ALFA (832)
--BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1 (722)
ANTIHEMOPHILIC FACTOR, PEGYLATED HUMAN SEQUENCE RECOMBINANT (352)
ANTI-INHIBITOR COAGULANT COMPLEX (317)
EMICIZUMAB (315)
DAMOCTOCOG ALFA PEGOL (310)
EFANESOCTOCOG ALFA (292)
ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT RESIDUES 743-1636 DELETED (180)